KalVista Pharmaceuticals (KALV) EBT Growth (3y) (2019 - 2025)
KalVista Pharmaceuticals (KALV) EBT Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 9.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 40.43% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 12.01% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 86.16% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | KalVista Pharmaceuticals | 1.36 Bn | 1.36 Bn | 49.41 Mn | -14.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 31, 2025 | -14.98% |
| Apr 30, 2025 | 2.55% |
| Oct 31, 2024 | -16.00% |
| Jul 31, 2024 | -22.33% |
| Apr 30, 2024 | 52.04% |
| Jan 31, 2024 | -30.52% |
| Oct 31, 2023 | -43.17% |
| Jul 31, 2023 | -38.00% |
| Apr 30, 2023 | -59.10% |
| Jan 31, 2023 | -37.09% |
| Oct 31, 2022 | -51.14% |
| Jul 31, 2022 | -57.74% |
| Apr 30, 2022 | -73.08% |
| Jan 31, 2022 | -82.15% |
| Oct 31, 2021 | -88.07% |
| Jul 31, 2021 | -45.00% |
| Apr 30, 2021 | -88.22% |
| Jan 31, 2021 | -42.02% |
| Oct 31, 2020 | -29.18% |
| Jul 31, 2020 | -35.32% |